One of the more exciting yet admittedly risky types of investing is buying into cheap drug developer stocks early in their company life cycle. That’s because the world of drug development and biotech ...

Makers of weight-loss drugs, the hottest segment of the pharmaceutical market just now, weren't looking so hot on the stock exchange Tuesday. A pronouncement from President Trump about the category ...

MongoDBMDB stock soared Wednesday after the database software company posted what one analyst called "one of its strongest quarters ever." The rally comes as MongoDB stock had been struggling in 2025, ...

It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and ...

That rival is ambitious clinical-stage biotech Viking Therapeutics. The company published its second-quarter results and business update after market close on Wednesday, and the obesity drug ...